Aranesp (darbepoetin alfa) Injection, 25 mcg Single-Dose Vial, 1 mL, 4/Package

Aranesp (darbepoetin alfa) is a recombinant erythropoiesis-stimulating agent indicated for the treatment of anemia associated with chronic kidney disease and for anemia in patients with non-myeloid malignancies receiving chemotherapy. Each single-dose vial contains 25 mcg of darbepoetin alfa in 1 mL of solution. Supplied as a package of 4 vials for convenient dosing.